Ensong Guo

1.5k total citations
22 papers, 467 citations indexed

About

Ensong Guo is a scholar working on Oncology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Ensong Guo has authored 22 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Obstetrics and Gynecology. Recurrent topics in Ensong Guo's work include COVID-19 Clinical Research Studies (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and COVID-19 and healthcare impacts (2 papers). Ensong Guo is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and COVID-19 and healthcare impacts (2 papers). Ensong Guo collaborates with scholars based in China, United States and Czechia. Ensong Guo's co-authors include Gang Chen, Chaoyang Sun, Wanying Shan, Bo Zhou, Rourou Xiao, Junbo Hu, Meng Xia, Hao Lü, Funian Lu and Danhui Weng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Ensong Guo

19 papers receiving 464 citations

Peers

Ensong Guo
Guiling Li China
Huaijun Zhou China
Nina Ohlson Sweden
Joanne Jeter United States
Laura Arenare Italy
Giuseppa Scandurra Italy
Luciano Mariani Italy
Nichole Peterson Canada
Guiling Li China
Ensong Guo
Citations per year, relative to Ensong Guo Ensong Guo (= 1×) peers Guiling Li

Countries citing papers authored by Ensong Guo

Since Specialization
Citations

This map shows the geographic impact of Ensong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ensong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ensong Guo more than expected).

Fields of papers citing papers by Ensong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ensong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ensong Guo. The network helps show where Ensong Guo may publish in the future.

Co-authorship network of co-authors of Ensong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ensong Guo. A scholar is included among the top collaborators of Ensong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ensong Guo. Ensong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiahui, Xiaoxiao Zhang, Xin Bai, et al.. (2025). Preoperative MRI-based predictive model for biochemical recurrence following radical prostatectomy. Abdominal Radiology. 50(10). 4687–4699.
2.
Fu, Yu, Xiaoyan Kang, Wenting Li, et al.. (2025). The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy. Cell Reports. 44(5). 115605–115605.
3.
Belada, David, M. A. Kwiatek, Franck Morschhauser, et al.. (2025). 158 | EPCORE DLBCL‐3: FIXED‐DURATION EPCORITAMAB MONOTHERAPY IN OLDER (≥ 75 Y), ANTHRACYCLINE‐INELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED LARGE B‐CELL LYMPHOMA (LBCL). Hematological Oncology. 43(S3). 2 indexed citations
4.
Morschhauser, Franck, David Belada, Johannes Duell, et al.. (2024). Epcore DLBCL-3 First Disclosure: Fixed-Duration Epcoritamab Monotherapy in Older (≥75 y), Anthracycline-Ineligible Patients with Previously Untreated Large B-Cell Lymphoma. Blood. 144(Supplement 1). 867–867. 4 indexed citations
5.
Guo, Ensong, et al.. (2021). Positive change in asthma control using therapeutic patient education in severe uncontrolled asthma: a one-year prospective study. SHILAP Revista de lepidopterología. 7(1). 10–10. 11 indexed citations
6.
Wang, Zhenkun, Ensong Guo, Bin Yang, et al.. (2021). Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer. Gynecologic Oncology. 163(2). 358–363. 68 indexed citations
7.
Huang, Jia, Wanying Shan, Fuxia Li, et al.. (2021). Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice. Aging. 13(5). 7589–7607. 17 indexed citations
8.
9.
Wang, Zizhuo, Rourou Xiao, Jia Huang, et al.. (2021). The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer. Microbial Ecology. 84(1). 302–313. 20 indexed citations
10.
Huang, Jia, Wanying Shan, Na Li, et al.. (2020). Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice. Reproductive BioMedicine Online. 42(3). 505–519. 45 indexed citations
11.
Yuan, Hai, Ensong Guo, Zhao Gao, Fengqi Hu, & Li Lu. (2020). Coronavirus Disease 2019 in a Hemodialysis Patient. Blood Purification. 49(6). 761–764. 6 indexed citations
12.
Li, Xi, Yu Fu, Bin Yang, et al.. (2020). BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages. Frontiers in Immunology. 11. 89–89. 27 indexed citations
13.
Liu, Chen, Yuhan Huang, Tianyu Qin, et al.. (2020). Six Gynecological Cancer Patients Infected With SARS-CoV-2 After Surgery or Radio-/Chemo-Therapy Treatment: Case Series. Frontiers in Oncology. 10. 1606–1606.
14.
Gao, Feng, et al.. (2020). [Analysis of clinical characteristics of 49 cases of COVID-19].. PubMed. 43(8). 654–658. 3 indexed citations
15.
Sun, Chaoyang, Xi Li, Ensong Guo, et al.. (2019). MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene. 39(8). 1681–1695. 64 indexed citations
16.
Sun, Chaoyang, Ensong Guo, Bo Zhou, et al.. (2019). A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients. BMC Cancer. 19(1). 1061–1061. 19 indexed citations
17.
Zhou, Bo, Hongbin Xu, Meng Xia, et al.. (2017). Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer. Frontiers of Medicine. 11(2). 214–222. 35 indexed citations
18.
Zhou, Bo, Chaoyang Sun, Na Li, et al.. (2016). Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways. International Journal of Oncology. 48(5). 2087–2097. 83 indexed citations
19.
Shan, Wanying, Chaoyang Sun, Bo Zhou, et al.. (2016). Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis. Oncotarget. 7(45). 72672–72684. 12 indexed citations
20.
Guo, Lili, Bo Zhou, Zhengqing Liu, et al.. (2016). Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling. Tumor Biology. 37(8). 11007–11015. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guiling Li Breakdown of academic impact, for papers by Huaijun Zhou Breakdown of academic impact, for papers by Nina Ohlson Breakdown of academic impact, for papers by Joanne Jeter Breakdown of academic impact, for papers by Laura Arenare Breakdown of academic impact, for papers by Giuseppa Scandurra Breakdown of academic impact, for papers by Luciano Mariani Breakdown of academic impact, for papers by Nichole Peterson
Rankless by CCL
2026